Bioscience Animal Health PCL (BKK:BIS)
Thailand · Delayed Price · Currency is THB 2.060
+0.060 (3.00%)
Jun 19, 2026, 4:38 PM ICT
BKK:BIS Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 37.39 | 38.47 | 65.04 | 50.71 | 55.92 | 72.4 |
Depreciation & Amortization | 18.62 | 19.67 | 17.78 | 16.04 | 15.72 | 17.37 |
Other Amortization | 1.01 | 1.01 | 0.91 | 0.41 | - | - |
Loss (Gain) From Sale of Assets | -0.42 | -0 | -0.53 | -1.1 | -10.3 | -0.5 |
Asset Writedown & Restructuring Costs | 1.11 | 1.11 | - | 0.34 | 0.02 | 0.77 |
Loss (Gain) From Sale of Investments | -1.14 | -1.17 | -0.04 | -0.04 | -0.21 | -0.27 |
Loss (Gain) on Equity Investments | - | - | - | - | - | -0.3 |
Provision & Write-off of Bad Debts | -3.54 | -4.24 | 3.8 | 5.78 | -4.75 | 0.67 |
Other Operating Activities | 51.82 | 52.04 | 16.53 | 4.99 | 8.58 | -9.39 |
Change in Accounts Receivable | 86.5 | 73.55 | 14.76 | -86.99 | -32.01 | -3.11 |
Change in Inventory | 32.77 | 20.69 | 80.08 | -71.97 | -49.92 | -45.7 |
Change in Accounts Payable | -9.98 | 82.35 | -61.41 | 107.73 | -27.29 | 4.64 |
Change in Other Net Operating Assets | 11.41 | -7.23 | -32.5 | -48.46 | 11.49 | 0.15 |
Operating Cash Flow | 225.53 | 276.25 | 104.4 | -22.56 | -32.74 | 36.73 |
Operating Cash Flow Growth | 45.44% | 164.59% | - | - | - | 63.83% |
Capital Expenditures | -3.57 | -2.16 | -5.91 | -6.1 | -14.51 | -18.24 |
Sale of Property, Plant & Equipment | 0.57 | 0 | 1.33 | 0.27 | 0.37 | 0.5 |
Cash Acquisitions | -2.36 | - | -11.08 | - | - | - |
Sale (Purchase) of Intangibles | -0.73 | -0.5 | -1.13 | -2.3 | -3.08 | -0.13 |
Sale (Purchase) of Real Estate | - | - | -0.22 | 4.19 | 28.31 | -0.29 |
Investment in Securities | -165.02 | -238.01 | 14.94 | 61.77 | -254.77 | 2.27 |
Other Investing Activities | -3.2 | -3.66 | -0.21 | 3.76 | 101.1 | 0.45 |
Investing Cash Flow | -174.33 | -244.33 | -2.27 | 61.59 | -142.58 | -15.44 |
Short-Term Debt Issued | - | - | 44 | - | - | 111.61 |
Long-Term Debt Issued | - | - | - | - | - | 25 |
Total Debt Issued | - | - | 44 | - | - | 136.61 |
Short-Term Debt Repaid | - | -43.98 | - | - | -254.75 | -39.63 |
Long-Term Debt Repaid | - | -7.52 | -6.06 | -3.2 | -51.76 | -47.26 |
Total Debt Repaid | -6.18 | -51.5 | -6.06 | -3.2 | -306.5 | -86.89 |
Net Debt Issued (Repaid) | -6.18 | -51.5 | 37.94 | -3.2 | -306.5 | 49.72 |
Issuance of Common Stock | - | - | - | - | 564 | - |
Common Dividends Paid | -53.38 | -53.38 | -37.68 | -32.19 | -109.04 | -22 |
Other Financing Activities | -0.94 | -2.82 | 0.4 | -0.86 | -23.16 | -2.15 |
Financing Cash Flow | -60.5 | -107.7 | 0.66 | -36.25 | 125.3 | 25.57 |
Foreign Exchange Rate Adjustments | - | - | - | 0.08 | - | - |
Net Cash Flow | -9.3 | -75.78 | 102.79 | 2.86 | -50.02 | 46.86 |
Free Cash Flow | 221.96 | 274.09 | 98.5 | -28.66 | -47.25 | 18.49 |
Free Cash Flow Growth | 45.94% | 178.27% | - | - | - | - |
Free Cash Flow Margin | 10.09% | 12.16% | 4.24% | -1.19% | -2.14% | 0.93% |
Free Cash Flow Per Share | 0.71 | 0.87 | 0.31 | -0.09 | -0.17 | 0.08 |
Cash Interest Paid | 0.76 | 2.94 | 0.85 | 1.8 | 6.38 | - |
Cash Income Tax Paid | 17.84 | 18.72 | 21.65 | 12.18 | 16.39 | 30.91 |
Levered Free Cash Flow | 211 | 259.42 | 109.59 | -34.37 | -64.72 | -0.58 |
Unlevered Free Cash Flow | 211.44 | 260.17 | 111.23 | -33.19 | -60.8 | 5.64 |
Change in Working Capital | 120.7 | 169.35 | 0.92 | -99.7 | -97.72 | -44.02 |